STOCK TITAN

Neurogene: Balyasny reports approximately 1.52% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Neurogene Inc. (NGNE) is the issuer in an amended beneficial-ownership disclosure by Balyasny Asset Management L.P., the investment manager of Atlas Diversified Master Fund, Ltd.; BAM GP LLC, the general partner of Balyasny Asset Management L.P.; Balyasny Asset Management Holdings LP, the sole member of BAM GP LLC; Dames GP LLC, the general partner of Balyasny Asset Management Holdings LP; and Dmitry Balyasny, the managing member of Dames GP LLC. Each reporting person may be deemed to beneficially own 303,994 common shares, approximately 1.52% of the class, with sole voting and dispositive power. Atlas Diversified Master Fund, Ltd. directly holds the shares and has the right to receive dividends and sale proceeds. Neurogene had 20,011,382 shares outstanding as of August 7, 2026.

Beneficially owned shares 303,994 shares Each of the five reporting persons may be deemed to beneficially own this amount.
Percent of class Approximately 1.52% Reported for each of the five reporting persons.
Shares outstanding 20,011,382 shares Neurogene shares outstanding as of August 7, 2026.
beneficially own financial
"may be deemed to beneficially own such Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
sole voting power technical
"Sole Voting Power 303,994.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power technical
"Sole Dispositive Power 303,994.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
investment manager financial
"the investment manager of Atlas Diversified Master Fund, Ltd."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NGNE shares did the Balyasny reporting persons report owning?

Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC and Dmitry Balyasny each may be deemed to beneficially own 303,994 Neurogene common shares, approximately 1.52% of the class.

Who directly holds the reported NGNE shares and receives dividends?

Atlas Diversified Master Fund, Ltd. directly holds the 303,994 shares and has the right to receive dividends and proceeds from their sale. It is described as a Cayman Islands exempted company and an investment management client of Balyasny Asset Management L.P.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





64135M105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BALYASNY ASSET MANAGEMENT L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:11/16/2026

Keep reading